Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16109363 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Glatiramer acetate

Indicates status has not been verified in more than two years